In DM-ILD patients, particularly those positive for MDA-5 antibodies, researchers have observed elevated levels of interleukin, specifically IL-6 and IL-10, which are pro-inflammatory cytokines [28, 29]. Here, IL6 is linked to interstitial lung disease.